Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -40.97% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -40.87% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -42.39% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -41.28% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -39.96% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -36.82% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -36.61% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -35.90% away from its yearly high level, during the last trading session. The

Inovio Pharmaceuticals, Inc., (NASDAQ: INO) was trading -32.25% away from its yearly high level, during the last trading session. The